Application 212156

Type
NDA
Sponsor
PAR STERILE PRODUCTS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MICAFUNGINMICAFUNGIN SODIUMINJECTABLE;INTRAVENOUS50MGNoNo
002MICAFUNGINMICAFUNGIN SODIUMINJECTABLE;INTRAVENOUS100MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N212156-001MICAFUNGINMICAFUNGIN SODIUMEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-16
N212156-002MICAFUNGINMICAFUNGIN SODIUMEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 70 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-1684e616aacf4f…
2026-09-14 22:38:342026-08N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-1684e616aacf4f…
2026-08-18 06:07:402026-07N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16caaa826d4ba7…
2026-08-18 06:07:402026-07N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-162680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d06236e962d9…
2024-10-29 15:01 UTC2024-10N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1679d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-161e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-168072bd15b7f6…
2024-05-31 18:47 UTC2024-05N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-164b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-164b0b4de00fa7…
2022-03-09 01:35 UTC2022-03N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16bb7c543d1eb4…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MicafunginMICAFUNGINHisun Pharmaceuticals USA, Inc.230fcff4-ad4b-ea25-e063-6394a90a1fab2026-04-14Warnings, Adverse reactionsName fallback
brand name: Micafungin
MicafunginMICAFUNGINZydus Lifesciences Limited72bc5dd6-6052-4483-9b13-afdeaaa8cc692025-12-22Name fallback
brand name: Micafungin
MicafunginMICAFUNGIN SODIUMSagent Pharmaceuticals33e579c1-b315-44cb-a690-e2dd2cdf44ee2025-11-08Warnings, Adverse reactionsName fallback
brand name: Micafungin
generic name: MICAFUNGIN SODIUM
MicafunginMICAFUNGIN SODIUMFresenius Kabi USA, LLCdc5241be-4b85-4f04-8553-9819603373b82025-10-23Warnings, Adverse reactionsName fallback
brand name: Micafungin
generic name: MICAFUNGIN SODIUM
MICAFUNGINMICAFUNGINGlenmark Pharmaceuticals Inc., USA31e74606-bccd-4276-bb20-a1933ce4ca252025-09-09Warnings, Adverse reactionsName fallback
brand name: MICAFUNGIN
MicafunginMICAFUNGIN SODIUMHikma Pharmaceuticals USA Inc.8ba6f80c-05f0-4d75-930c-c8458db2e1c12025-08-22Warnings, Adverse reactionsName fallback
brand name: Micafungin
generic name: MICAFUNGIN SODIUM
MicafunginMICAFUNGINZydus Pharmaceuticals USA Inc.29f17423-5787-47d0-a83b-bbdc0198fbfa2025-01-20Warnings, Adverse reactionsName fallback
brand name: Micafungin
MicafunginMICAFUNGIN SODIUMFresenius Kabi USA, LLCf8198836-4011-40b9-af25-466ae08727f82024-10-09Warnings, Adverse reactionsName fallback
brand name: Micafungin
generic name: MICAFUNGIN SODIUM
MicafunginMICAFUNGIN SODIUMMeitheal Pharmaceuticals Inc.579ff093-0359-4e0e-a6ea-2b6adac80bf02024-08-13Warnings, Adverse reactionsName fallback
brand name: Micafungin
generic name: MICAFUNGIN SODIUM
MICAFUNGINMICAFUNGINQilu Pharmaceutical Co., Ltd653f8c75-b5b8-41ea-8b33-5baad1680bda2024-05-10Warnings, Adverse reactionsName fallback
brand name: MICAFUNGIN
MICAFUNGINMICAFUNGINBiocon Pharma Inc.5a74d7e9-1ca2-37dd-cbcf-d7fde1f5a6062023-10-04Warnings, Adverse reactionsName fallback
brand name: MICAFUNGIN
MycamineMICAFUNGIN SODIUMAstellas Pharma US, Inc.a064c4a7-25ec-4a2c-afc2-703491a4a38b2020-07-23Warnings, Adverse reactionsName fallback
generic name: MICAFUNGIN SODIUM

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42023-229MicafunginMicafunginPar Pharmaceutical, Inc.NDACurrent
42023-229MicafunginMicafunginPar Pharmaceutical, Inc.NDACurrent
42023-230MicafunginMicafunginPar Pharmaceutical, Inc.NDACurrent
42023-230MicafunginMicafunginPar Pharmaceutical, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
69653ORIG2021-12-20
69457ORIG2021-12-03
67841ORIG2021-06-17